AVROBIO Inc.
AVRO
NGS
Sector: Healthcare
Industry: Biotechnology
1.07
USD
0.03
(2.88%)
Optionable: Yes Market Cap: 44 M 90-day average vol: 403,768
Previous close: 1.04 Open: 1.07 Bid: 1.05 Ask: 1.05
52 week range
0.74 6.88
Last updated: Sunday 14th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
AVROBIO to Present at Two Upcoming Investor Conferences in March
Yahoo Finance 3/1/2022
2 Net Current Asset Value Stocks to Consider
Yahoo Finance 2/21/2022
AVROBIO (AVRO) Presents At AVROBIO WORLD Symposium 2022 Cystinosis
Seeking Alpha 2/14/2022
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
Yahoo Finance 2/9/2022
AVROBIO gains after interim data from cystinosis study for gene therapy
Seeking Alpha 2/9/2022
AVROBIO Reports Interim Data from Phase 1/2 Clinical Trial of Investigational Gene Therapy for Cystinosis
Yahoo Finance 2/9/2022
AVROBIO Inc. (AVRO) Reprioritizes Pipeline Programs, Presentation - Slideshow
Seeking Alpha 2/7/2022
Avrobio announces inducement grants to three new employees
Seeking Alpha 2/4/2022
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance 2/4/2022
Here's Why AVROBIO, Inc. (AVRO) is Poised for a Turnaround After Losing 19.7% in 4 Weeks
Yahoo Finance 2/3/2022
AVROBIO Announces the Appointment of Sean O’Bryan as Chief Regulatory Officer
Yahoo Finance 2/1/2022
AVROBIO to Present at Cowen’s 2nd Annual Genetic Medicines Summit
Yahoo Finance 1/28/2022
AVROBIO to Present New Data from Phase 1/2 Clinical Trial in Cystinosis at WORLDSymposium™ 2022
Yahoo Finance 1/27/2022
Bears are Losing Control Over AVROBIO, Inc. (AVRO), Here's Why It's a 'Buy' Now
Yahoo Finance 1/25/2022
Here's Why AVROBIO, Inc. (AVRO) is Poised for a Turnaround After Losing 44.1% in 4 Weeks
Yahoo Finance 1/7/2022
AVROBIO grants non-statutory stock options to three new employees
Seeking Alpha 1/6/2022
AvroBio shares plunge after company halts development of Fabry drug
Yahoo Finance 1/4/2022
Wedbush Says Avrobio Shares Still Undervalued Despite 33% Fall
Yahoo Finance 1/4/2022
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!